R

Ralph Weichselbaum

Tianjin University of Science and Technology

Publishes on Head and Neck Cancer Studies, Virus-based gene therapy research, Cancer Research and Treatments. 71 papers and 4.7k citations.

71Publications
4.7kTotal Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Speech and Survival
Barbara J. McNeil, Ralph Weichselbaum, Stephen G. Pauker|New England Journal of Medicine|1981
Cited by 683

In State T3 carcinoma of the larynx (carcinoma restricted to the vocal cords, causing complete immobility of the cords but not extending to adjacent structures), laryngectomy leads to a three-year survival rate of approximately 60 per cent and the loss of normal speech. Radiation therapy, on the other hand, leads to a lower survival (30 to 40 per cent at three years) but preserves normal or nearly normal speech. We investigated attitudes toward the quantity and quality of life in 37 healthy volunteers, interviewing 12 firefighters and 25 middle and upper management executives to determine their preferences for longevity and voice preservation. We used the principles of expected utility theory to develop a method for sharpening decisions involving tradeoffs between quantity and quality of life. Our analysis indicates that to maintain their voices, approximately 20 per cent of volunteers would choose radiation instead of surgery. These results suggest that treatment choices should be made on the basis of patients' attitudes toward the quality as well as the quantity of survival.

Fallacy of the Five-Year Survival in Lung Cancer
Barbara J. McNeil, Ralph Weichselbaum, Stephen G. Pauker|New England Journal of Medicine|1978
Cited by 479

Patients with lung cancer can be treated by either surgical extirpation or radiation. The former may offer increased five-year survival and prolonged life expectancies as compared to the latter, but subjects patients to the immediate risk of thoracotomy. We interviewed patients with "operable" lung cancer and found that they were quite averse to taking risks involving the possibility of immediate death. When these data about patients' attitudes were combined with data about survival after both radiation therapy and operation, it appeared that radiotherapy would be the preferred therapeutic plan for several of these patients. These results emphasize the importance of choosing therapies not only on the basis of objective measures of survival but also on the basis of patient attitudes.